Utama › Adenokarsinoma Esofagus › Illinois

Kajian klinikal Adenokarsinoma Esofagus di Illinois

11 kajian untuk Adenokarsinoma Esofagus sedang mencari peserta di lokasi di Illinois.

Bandar di Illinois

Teks kajian rasmi (Bahasa Inggeris)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
dan 37 lagi

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
dan 54 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05677490

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Orchard Healthcare Research Inc.- Skokie, Skokie

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06324357

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Local Institution - 0379, Chicago

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07221149

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Illinois Cancer Specialists, Arlington Heights
Illinois CancerCare - Bloomington, Bloomington
Illinois Cancer Specialists, Chicago
dan 7 lagi

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Chicago, Zion

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Northwestern Memorial Hospital, Chicago

Mengambil peserta

Umur 18 hingga 89 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Chicago
Research Site, Niles
Research Site, Zion

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07431281

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Orchard Healthcare Research Inc, Skokie

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
dan 13 lagi

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Northwestern University, Chicago

Mengambil peserta

Umur 18 hingga 89 · Semua jantina · Dikemas kini 1 Jul 2026 · NCT05530343

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.